THE NONINVASIVE
OPTION FOR AVERAGE-
RISK PATIENTS WHO
AVOID COLONOSCOPY
Cologuard is a registered trademark of Exact Sciences Corporation.
©2015 Exact Sciences Corporation. All rights reserved. CG-00190-01-February 2015
Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the
presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer
(CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy. Cologuard is indicated
to screen adults of either sex, 50 years or older, who are at typical average-risk for CRC. Cologuard is not a
replacement for diagnostic colonoscopy or surveillance colonoscopy in high risk individuals. Rx only.
1. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(4):1987-97.
Cologuard is the colorectal cancer screening
test that uses innovative stool DNA technology
to detect cancer with 92% sensitivity and 87%
specificity.
1
It's noninvasive and easy to use,
with no special preparation required. No wonder
patients are excited—and you will be, too.
Covered by Medicare. CologuardTest.com.
